guidelines — open questions (round 5)
- What does the 2026 AAD paediatric atopic dermatitis guideline recommend for under-5s (TCS potency, TCIs below age 2, crisaborole/ruxolitinib, bleach baths, wet wraps)?
- Is NICE planning a full update of CG57, given most recommendations still date from 2007 (e.g. TCIs, antihistamines, wet wraps)?
- Does the NEA Seal of Acceptance have any outcome evidence (fewer flares or contact reactions) versus non-Seal products in young children?